Acceleron Pharma reported $0 in Loan Capital for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Acceleron Pharma XLRN:US $ 0M 0M
Akebia Therapeutics AKBA:US $ 97.23M 0.31M
Alexion Pharmaceuticals ALXN:US $ 2388.8M 30.8M
Amgen AMGN:US $ 33291M 4833M
Arena Pharmaceuticals ARNA:US $ 37.48M 1.3M
Bayer BAYN:GR € 36974M 310M
Biomarin Pharmaceutical BMRN:US $ 1078.09M 0.98M
Bluebird Bio BLUE:US $ 0M 0M
Clovis Oncology CLVS:US $ 599.54M 16.41M
Dicerna Pharmaceuticals DRNA:US $ 0M 0M
Eli Lilly And LLY:US $ 15522.4M 785.8M
Exelixis EXEL:US $ 0M 0M
GlaxoSmithKline GSK:LN 20736M 294M
Karyopharm Therapeutics KPTI:US $ 301.57M 195K
Mirati Therapeutics MRTX:US $ 0M 0M
Neurocrine Biosciences NBIX:US $ 330.7M 4.4M
Novartis NOVN:VX SF 24715M 1776M
Ptc Therapeutics PTCT:US $ 972.21M 143.17M
Puma Biotechnology PBYI:US $ 96.8M 28.1M
Regeneron Pharmaceuticals REGN:US $ 1979.6M 0.4M
Rigel Pharmaceuticals RIGL:US $ 19.89M 0.03M
Sangamo Biosciences SGMO:US $ 0M 0M
Ultragenyx Pharmaceutical RARE:US $ 0M 0M
United Therapeutics UTHR:US $ 800M 0M
Vertex Pharmaceuticals VRTX:US $ 513.26M 11.67M